Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Interest Coverage Ratio of 15.07 for Q2 2026, up 211.76% year-over-year from 4.83 in Q2 2025, and up 255.34% on a QoQ basis from 9.7 in Q1 2026.
Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Interest Coverage Ratio for 6 years, with the latest figure at 15.07 in Q2 2026.
- Interest Coverage Ratio for Q2 2026 came in at 15.07, up 211.76% year-over-year; the trailing twelve-month figure through Jun 2026 was 6.93 (up 64.17% YoY), and the FY2025 annual result was 0.7, up 35.48% from the prior year.
- Interest Coverage Ratio rose to 15.07 in Q2 2026, from 9.7 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 656.39 in Q4 2024 and troughed at 71.06 in Q1 2023.
- A 4-year average of 33.82 and a median of 11.27 in 2026 frame the typical range for Interest Coverage Ratio.
- The largest YoY upside for Interest Coverage Ratio was 5214.57% in 2024 against a maximum downside of 161.34% in 2024.
- A 4-year view of Interest Coverage Ratio shows it stood at 12.83 in 2023, then jumped by 5214.57% to 656.39 in 2024, then slumped by 101.05% to 6.88 in 2025, then surged by 319.05% to 15.07 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 15.07 in Q2 2026, 9.7 in Q1 2026, and 6.88 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 1.42 |
| 10 | Werewolf Therapeutics | 43.49 Mn | 43.49 Mn | - | 15.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.07 |
| Mar 31, 2026 | -9.70 |
| Dec 31, 2025 | -3.22 |
| Sep 30, 2025 | -6.71 |
| Jun 30, 2025 | -6.06 |
| Mar 31, 2025 | -14.24 |
| Dec 31, 2024 | -16.06 |
| Sep 30, 2024 | -13.77 |
| Jun 30, 2024 | -16.60 |
| Mar 31, 2024 | -17.11 |
| Dec 31, 2023 | -12.83 |
| Sep 30, 2023 | -9.23 |
| Jun 30, 2023 | -6.35 |
| Mar 31, 2023 | -71.06 |
| Dec 31, 2020 | -0.63 |